Skip to main content
Explore URMC

Eran Tallis, M.D.


Showing all 9 journal articles & 0 books available

Journal Articles

Kurtz KJ, Tallis E, Marcogliese AN, Pulivarthi RH, Potocki L, Stevens AM. "Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome." Pediatric hematology and oncology.. 2022 Nov; 39(8):747-754. Epub 2022 Mar 11.

Lucari B, Tallis E, Sutton VR, Porea T. "Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma." Pediatric hematology and oncology.. 2022 Sep 20; :1-7. Epub 2022 Sep 20.

Tallis E, Karsenty CL, Grimes AB, Karam LB, Elsea SH, Sutton VR, Rawls-Castillo BL, Liu N, Soler-Alfonso C. "Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment." JIMD reports.. 2022 Jul; 63(4):309-315. Epub 2022 May 22.

Tallis E, Scollon S, Ritter DI, Plon SE. "Evolution of germline TP53 variant classification in children with cancer." Cancer genetics.. 2022 Jun; 264-265:29-32. Epub 2022 Mar 03.

Lu S, Tallis E, Ding X, Li D, Cox K, You MJ, St John L, Alatrash G, Ma Q, Molldrem JJ. "Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia." Cytotherapy.. 2021 Sep; 23(9):793-798. Epub 2021 Jun 30.

Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N. "Patient with mixed-phenotype acute leukemia with rearrangement." Leukemia & lymphoma.. 2019 Nov; 60(11):2829-2831. Epub 2019 Apr 23.

Ma Q, Garber HR, Lu S, He H, Tallis E, Ding X, Sergeeva A, Wood MS, Dotti G, Salvado B, Ruisaard K, Clise-Dwyer K, John LS, Rezvani K, Alatrash G, Shpall EJ, Molldrem JJ. "A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells." Cytotherapy.. 2016 Aug; 18(8):985-994. Epub 2016 Jun 02.

Shimoni A, Shem-Tov N, Chetrit A, Volchek Y, Tallis E, Avigdor A, Sadetzki S, Yerushalmi R, Nagler A. "Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced." Leukemia.. 2013 Apr; 27(4):829-35. Epub 2012 Oct 17.

Tallis E, Rudensky B, Attias D, Raveh D, Schlesinger Y, Yinnon AM. "In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus." Diagnostic microbiology and infectious disease.. 1999 Oct; 35(2):121-6.